A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

NCT05864391 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped AstraZeneca have decided to not move forward with the development of the compound.

Conditions

Interventions

Sponsor

AstraZeneca